Literature DB >> 31317312

Atrial fibrillation and kidney disease: insights on a close relationship.

Giorgio Trivioli1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31317312     DOI： 10.1007/s11739-019-02141-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  37 in total

Review 1.  Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies.

Authors:  António Nogueira; Maria João Pires; Paula Alexandra Oliveira
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

2.  Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation.

Authors:  A Goette; T Staack; C Röcken; M Arndt; J C Geller; C Huth; S Ansorge; H U Klein; U Lendeckel
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

3.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation.

Authors:  A Frustaci; C Chimenti; F Bellocci; E Morgante; M A Russo; A Maseri
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

4.  Atrial fibrillation and risk of stroke in dialysis patients.

Authors:  James B Wetmore; Edward F Ellerbeck; Jonathan D Mahnken; Milind Phadnis; Sally K Rigler; Purna Mukhopadhyay; John A Spertus; Xinhua Zhou; Qingjiang Hou; Theresa I Shireman
Journal:  Ann Epidemiol       Date:  2013-01-16       Impact factor: 3.797

5.  Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency.

Authors:  Michael G Shlipak; Linda F Fried; Casey Crump; Anthony J Bleyer; Teri A Manolio; Russell P Tracy; Curt D Furberg; Bruce M Psaty
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690

Review 6.  Atrial fibrillation and chronic kidney disease: A review of options for therapeutic anticoagulation to reduce thromboembolism risk.

Authors:  Harpreet S Bhatia; Jonathan C Hsu; Robert J Kim
Journal:  Clin Cardiol       Date:  2018-10-25       Impact factor: 2.882

7.  Improvement in endothelium dysfunction in diabetics treated with statins: a randomized comparison of atorvastatin 20 mg versus rosuvastatin 10 mg.

Authors:  Natale Daniele Brunetti; Guglielmo Maulucci; Grazia Pia Casavecchia; Carlo Distaso; Luisa De Gennaro; Pier Luigi Pellegrino; Matteo Di Biase
Journal:  J Interv Cardiol       Date:  2007-12       Impact factor: 2.279

8.  Inflammation as a risk factor for atrial fibrillation.

Authors:  Ronnier J Aviles; David O Martin; Carolyn Apperson-Hansen; Penny L Houghtaling; Pentti Rautaharju; Richard A Kronmal; Russell P Tracy; David R Van Wagoner; Bruce M Psaty; Michael S Lauer; Mina K Chung
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

9.  Atrial Fibrillation and Risk of ESRD in Adults with CKD.

Authors:  Nisha Bansal; Dawei Xie; Kelvin Tao; Jing Chen; Rajat Deo; Edward Horwitz; Chi-Yuan Hsu; Radha Krishna Kallem; Martin G Keane; Claudia M Lora; Dominic Raj; Elsayed Z Soliman; Louise Strauss; Myles Wolf; Alan S Go
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-12       Impact factor: 8.237

10.  Gene expression profiling of oxidative stress on atrial fibrillation in humans.

Authors:  Young Hoon Kim; Do Sun Lim; Ji Hye Lee; Do-Sun Lim; Wan Joo Shim; Young Moo Ro; Gil Hong Park; Kevin G Becker; Yoon S Cho-Chung; Meyoung-Kon Kim
Journal:  Exp Mol Med       Date:  2003-10-31       Impact factor: 8.718
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.